Table 1.
Characteristics of Patients in the Online and Nononline IO Groups
| Characteristic | Treatment Groups (n = 49); n (%) |
P | |
|---|---|---|---|
| Online Group (n = 23) | Nononline Group (n = 26) | ||
| Age; mean ± SD | 61.7 ± 12.2 | 62.85 ± 12.7 | 0.75 |
| Gender | |||
| Female | 21 (91%) | 18 (69%) | 0.08 |
| Language | |||
| Hebrew | 19 (83%) | 16 (62%) | 0.12 |
| Arabic | 0 | 4 (15%) | 0.11 |
| Russian | 4 (17%) | 6 (23%) | 0.73 |
| Country of birth | |||
| Israeli born | 14 (61%) | 15 (58%) | 1.00 |
| Residence | |||
| Haifa and suburbs | 18 (78%) | 20 (77%) | 1.00 |
| Cancer site | |||
| Breast cancer | 14 (61%) | 7 (27%) | 0.022 |
| Cancer recurrence | |||
| Yes | 6 (26%) | 4 (16%) | 0.48 |
| Evidence of metastasis | |||
| Yes | 7 (30%) | 18 (69%) | 0.01 |
| Oncology setting | |||
| Palliative | 8 (35%) | 18 (69%) | 0.022 |
| Prior complementary medicine use for noncancer-related indications | |||
| Yes | 16 (70%) | 22 (88%) | 0.16 |
| Complementary medicine use for cancer-related indications | |||
| Yes | 11 (48%) | 10 (40%) | 0.77 |
| Adherence to integrative care (six weeks) | |||
| Yes | 23 (100%) | 17 (65%) | 0.002 |
IO = integrative oncology.